- Home
- BBD vs BNTX Comparison
BBD vs BNTX Comparison
Compare BBD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- BNTX
- Stock Information
- Founded
- BBD 1943
- BNTX 2008
- Country
- BBD Brazil
- BNTX Germany
- Employees
- BBD N/A
- BNTX N/A
- Industry
- BBD Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBD Finance
- BNTX Health Care
- Exchange
- BBD Nasdaq
- BNTX Nasdaq
- Market Cap
- BBD 24.0B
- BNTX 23.9B
- IPO Year
- BBD N/A
- BNTX 2019
- Fundamental
- Price
- BBD $1.93
- BNTX $114.13
- Analyst Decision
- BBD Buy
- BNTX Strong Buy
- Analyst Count
- BBD 3
- BNTX 15
- Target Price
- BBD $3.20
- BNTX $143.50
- AVG Volume (30 Days)
- BBD 39.8M
- BNTX 659.5K
- Earning Date
- BBD 02-05-2025
- BNTX 11-04-2024
- Dividend Yield
- BBD 2.00%
- BNTX N/A
- EPS Growth
- BBD 8.84
- BNTX N/A
- EPS
- BBD 0.25
- BNTX N/A
- Revenue
- BBD $13,847,063,319.00
- BNTX $3,390,698,192.00
- Revenue This Year
- BBD N/A
- BNTX N/A
- Revenue Next Year
- BBD $10.66
- BNTX N/A
- P/E Ratio
- BBD $7.12
- BNTX N/A
- Revenue Growth
- BBD 17.49
- BNTX N/A
- 52 Week Low
- BBD $1.84
- BNTX $76.53
- 52 Week High
- BBD $3.56
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- BBD 35.55
- BNTX 49.15
- Support Level
- BBD $1.88
- BNTX $109.52
- Resistance Level
- BBD $1.96
- BNTX $115.34
- Average True Range (ATR)
- BBD 0.07
- BNTX 4.74
- MACD
- BBD -0.00
- BNTX -0.80
- Stochastic Oscillator
- BBD 27.27
- BNTX 29.03
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. Banking provides roughly 70% of profits, while the insurance segment contributes the remaining 30%. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.